Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Vertex Pharmaceuticals, Inc. (NQ: VRTX)
77.87 USD  -0.93 (-1.18%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Vertex Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Vertex Pharmaceuticals Up 77.9% Since SmarTrend Uptrend Call (VRTX)
June 18, 2013
from Comtex SmarTrend® News Briefs
Vertex Pharmaceuticals, Inc. Moves Up In Market Cap Rank, Passing Intuit Inc
June 18, 2013
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Vertex Pharmaceuticals, Inc. (VRTX) was identified as having a larger market cap than the smaller end of... Read More
category Stocks
from Market News Video
MDY, VRTX, AME, GMCR: Large Outflows Detected at ETF
June 18, 2013
Symbols mentioned in this story: MDY, VRTX, AME, GMCR Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Jefferies Says Analysis on Elan Supports $19/Share Takeover Bid, Lifts Price Target to $19
June 18, 2013
In a report from Jefferies' Corey Davis published Tuesday, the analyst suggested Elan (NYSE: ELN ) execs have indicated they may agree or strongly consider a takeover anywhere between $15 to $20 per... Read More
category ELN , Benzinga , REGN , and 11 more.
from Latest Articles from Benzinga.com
Elan Corp (ELN) Could Be Worth $19 in a Takeout - Jefferies
June 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8425504 for the full story. Read More
from StreetInsider.com News Articles
Commit To Purchase Vertex Pharmaceuticals At $55, Earn 13.3%
June 14, 2013
Investors eyeing a purchase of Vertex Pharmaceuticals, Inc. (VRTX) stock, but tentative about paying the going market price of $80.55/share, might benefit from considering selling puts among the... Read More
category Dividends
from Dividend Channel
Bio-Wire Equity Surveillance – Closing Bell 6/13/2013
June 13, 2013
Thursday, June 13th, 2013 DJIA: +1.21% to 15,176.08 S&P 500: +1.48% to 1,636.36 NASDAQ: +1.32% to 3,445.37 NYSE Arca – Pharma Index: +1.05% to 429.90 Big pharma (Mkt Cap $10 B+) +1.03% Mid-sized pharma... Read More
category MYGN , MRK , Bio/Wire , and 1 more.
from Bio-Wire.Com
Vertex Pharmaceuticals Incorporated - Trading Recap
June 13, 2013
NEW YORK (AVAFIN) -- The average ten day put volume is 1,768. The intraday ... Read More
from AVAFIN
Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB)
June 12, 2013
Among biotech and emerging pharmaceutical companies, Biogen Idec (NASDAQ: BIIB ), saw the most significant rise in short interest between the May 15 and May 31 settlement dates. The number of shares... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Bio-Wire Equity Surveillance – Closing Bell 6/7/2013
June 07, 2013
Thursday, June 6th, 2013 Overview Today was bullish for the broader market with the Dow moving+1.38% to 15,248, the S&P 500 moving +1.28% to 1643 and the NASDAQ moving+1.32% to 3469. Big pharma... Read More
category ICUI , QCOR , AMRN , and 4 more.
from Bio-Wire.Com
Mid-Afternoon Market Update: Markets Cool Off Slightly, Vertex Rises
June 07, 2013
Toward the end of trading Friday, the Dow traded up 1.08 percent to 15,203.44 while the NASDAQ gained 1.09 percent to 3,461.34. The S&P also rose, surging 0.98 percent to 1,638.88. Top Headline... Read More
category Earnings , Benzinga , Movers , and 16 more.
from Latest Articles from Benzinga.com
Vertex Pharmaceuticals Crosses Above its 10-day MA (VRTX)
June 07, 2013
from Comtex SmarTrend® News Briefs
Vertex Pharmaceuticals Has Returned 79.9% Since SmarTrend Recommendation (VRTX)
June 04, 2013
from Comtex SmarTrend® News Briefs
New drugs trail many old ones in effectiveness against disease
June 03, 2013
NEW YORK, June 3 (Reuters) - Despite the more than $50 billion that U.S. pharmaceutical companies have spent every year since the mid-2000s to discover new medications, drugmakers have barely improved... Read More
category companyNews
from Reuters: Company News
3 ways to play the biotech boom
June 03, 2013
If you want to join in the biotech boom, these funds offer varying levels of risk and protection, writes Jeff Reeves. Read More
category REGN , Biotechnology , Opinion , and 24 more.
from MarketWatch
Will Hepatitis C Become A New Battleground Between Pharma And Poor Nations?
May 31, 2013
Will the new crop of hepatitis C treatments form the next battleground between the pharmaceutical industry, poor nations and patient advocates? A new report from the Global Commission on Drug Policy,... Read More
category NYSE:JNJ , NASDAQ:VRTX , NASDAQ:GILD
from Forbes Real Time
Short Interest in Vertex Rises, in Biogen Idec Falls
May 29, 2013
Among biotech and emerging pharmaceutical companies, Regeneron Pharmaceuticals (NASDAQ: REGN ) and Vertex Pharmaceuticals (NASDAQ: VRTX ) saw he most significant rise in short interest between the... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 36 more.
from Latest Articles from Benzinga.com
Vertex Pharmaceuticals Up 78.6% Since SmarTrend Uptrend Call (VRTX)
May 28, 2013
from Comtex SmarTrend® News Briefs
Earnings Look Back: Vertex Pharmaceuticals Is Up 3.5% Since Reporting Quarterly Results 2 Weeks Ago (VRTX)
May 20, 2013
from Comtex SmarTrend® News Briefs
Pharma's R&D Deals With Foundations May Negatively Impact Image
May 20, 2013
On the surface, it sounds pretty reasonable. Foundations like the Michael J. Fox Foundation and the Cystic Fibrosis Foundation (CFF), in their attempts to accelerate the discovery and development of... Read More
category NASDAQ:VRTX , NYSE:PFE
from Forbes Real Time
MDY, VRTX, KSU, AME: Large Inflows Detected at ETF
May 16, 2013
Symbols mentioned in this story: MDY, VRTX, KSU, AME Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Vertex Pharmaceuticals Crosses Above its 10-day MA (VRTX)
May 10, 2013
from Comtex SmarTrend® News Briefs
S&P Highlights Biotech ETFs
May 10, 2013
Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis, biotechnology stocks... Read More
category Benzinga , ETFs , PJP , and 22 more.
from Latest Articles from Benzinga.com
Orphan Drug Companies Might Not Find A Parent
May 08, 2013
by Olga Oksman Read More
category NASDAQ:VRTX , EURONEXTPARIS:SNY , NASDAQ:NPSP , and 2 more.
from Forbes Real Time
MDY, VRTX, REGN, KSU: ETF Outflow Alert
May 08, 2013
Symbols mentioned in this story: MDY, VRTX, REGN, KSU Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Many in U.S. don't get proper testing for hepatitis C- CDC
May 07, 2013
NEW YORK, May 7 (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, U.S. health officials said on... Read More
category companyNews
from Reuters: Company News
Big Profits in Big Pharma
May 06, 2013
Don't let the less-than-stellar first quarter performances of a few well-known drug makers spook you: "Big Pharma" is a good investment over the long haul. Read More
from Update Content Feed for Financial Content
EPR adds FB, ARNA and VRTX to their Nasdaq Active Stock Watch List
May 03, 2013
from ACCESSWIRE
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
May 02, 2013
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential Source: George S. Mack of The Life Sciences Report (5/2/13) http://www.thelifesciencesreport.com/pub/na/15211 In January 2013, The... Read More
category GALE , NVS , ONXX , and 17 more.
from Bio-Wire.Com
< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster
2
The Future of Android Looks More Like Apple Inc.
Mike Schuster
3
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
TM Meyer
4
The Waning Integrity of US Financial Markets
Todd Harrison
5
Tech News: Tesla Motors Inc's First Recall Is a Display of Public Relations Prowess
Josh Wolonick